Ixazomib + Pomalidomide + Dexamethasone In MM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Takeda
Related studies linked through entity extraction aliases.
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-988 in Healthy Participants
- Status
- WITHDRAWN
- Phase
- PHASE1
Study Augmenting TAK-659 Action in Relapsed/Refractory AML by Addition Ofthe Proteasome Inhibitor Ixazomib
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal Fistula
- Status
- COMPLETED
- Phase
- PHASE3
A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Intratumoral Microdosing of TAK-981 in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
FIRAZYR General Drug Use-Results Survey (Japan)
- Status
- COMPLETED
- Phase
- N/A
Event-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer Subjects
- Status
- COMPLETED
- Phase
- N/A
Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Investigation of the Faecal Loss of Vedolizumab and Its Role in Influencing Serum Drug Levels, Outcomes and Response in Ulcerative Colitis
- Status
- UNKNOWN
- Phase
- PHASE4
Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn's Disease]
- Status
- COMPLETED
- Phase
- N/A
Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose
- Status
- COMPLETED
- Phase
- PHASE3
Validation Study: Mobile DSST on Cognition in Adults With MDD
- Status
- COMPLETED
- Phase
- NA
A Study to Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM)
- Status
- COMPLETED
- Phase
- PHASE1
Perianal Fistula (PAF) Validation and Burden of Illness Study
- Status
- COMPLETED
- Phase
- N/A
A Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Autoinjector (PFS+AI) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Pilot Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Autoinjector (PFS+AI) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Needle Safety Device (PFS+NSD) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Pilot Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Needle Safety Device (PFS+NSD) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1